Ana Flores-Chova
Overview
Explore the profile of Ana Flores-Chova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flores-Chova A, Martinez-Arroyo O, Puertes A, Vela-Bernal S, Gorriz J, Solis-Salguero M, et al.
Am J Nephrol
. 2025 Mar;
:1-19.
PMID: 40081350
Introduction: Little is known about the biofluid specificity of microRNAs (miRNAs) in systemic lupus erythematosus (SLE) and the biofluid influence on miRNA diagnosis and prognosis accuracy. Our aim was to...
2.
Enrichment of RedoxifibromiR miR-21-5p in Plasma Exosomes of Hypertensive Patients with Renal Injury
Martinez-Arroyo O, Flores-Chova A, Mendez-Debaets M, Martinez-Hervas S, Martinez F, Forner M, et al.
Int J Mol Sci
. 2025 Jan;
26(2).
PMID: 39859307
Several microRNAs (miRNAs) emerged as powerful regulators of fibrotic processes, "fibromiRs", and can also influence the expression of genes responsible for the generation of reactive oxygen species, "redoximiRs". We aimed...
3.
Martinez-Arroyo O, Flores-Chova A, Sanchez-Garcia B, Redon J, Cortes R, Ortega A
Biology (Basel)
. 2023 May;
12(5).
PMID: 37237503
Diabetic nephropathy is a major complication in diabetic patients. Podocytes undergo loss and detachment from the basal membrane. Intra- and intercellular communication through exosomes are key processes for maintaining function,...
4.
Flores-Chova A, Martinez-Arroyo O, Riffo-Campos A, Ortega A, Forner M, Cortes R
Int J Mol Sci
. 2023 Apr;
24(8).
PMID: 37108249
Despite considerable progress in our understanding of systemic lupus erythematosus (SLE) pathophysiology, patient diagnosis is often deficient and late, and this has an impact on disease progression. The aim of...
5.
Martinez-Arroyo O, Ortega A, Flores-Chova A, Sanchez-Garcia B, Garcia-Garcia A, Chaves F, et al.
Eur J Intern Med
. 2023 Apr;
113:49-56.
PMID: 37080818
Background: Endothelial dysfunction is a forerunner of atherosclerosis, leading to cardiovascular disease, and albuminuria is a marker of endothelial dysfunction. Circulating levels of microRNAs are emerging as potential biomarkers for...
6.
Riffo-Campos A, Perez-Hernandez J, Martinez-Arroyo O, Ortega A, Flores-Chova A, Redon J, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563588
Non-coding RNA (ncRNA)-mediated targeting of various genes regulates the molecular mechanisms of the pathogenesis of hypertension (HTN). However, very few circulating long ncRNAs (lncRNAs) have been reported to be altered...
7.
Riffo-Campos A, Perez-Hernandez J, Ortega A, Martinez-Arroyo O, Flores-Chova A, Redon J, et al.
Int J Mol Sci
. 2022 Jan;
23(2).
PMID: 35055008
Non-coding RNA (ncRNA), released into circulation or packaged into exosomes, plays important roles in many biological processes in the kidney. The purpose of the present study is to identify a...